MATINAS BIOPHARMA HOLDINGS, INC. Stock Issued During Period, Shares, Acquisitions
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- MATINAS BIOPHARMA HOLDINGS, INC. stock issued during period, shares, acquisitions for the quarter ending 2021-12-31 was 0.00 shares.
- MATINAS BIOPHARMA HOLDINGS, INC. stock issued during period, shares, acquisitions for the quarter ending 2021-09-30 was 1.50M shares.
- MATINAS BIOPHARMA HOLDINGS, INC. stock issued during period, shares, acquisitions for fiscal 2021 was 1.50M shares.
| Period end | Stock Issued During Period, Shares, Acquisitions 3 month | Stock Issued During Period, Shares, Acquisitions 12 month |
|---|---|---|
| 2021-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | 1.50M shares 10-K · filed 2023-03-15 |
| 2021-09-30 | 1.50M shares 10-Q · filed 2022-11-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B |